✦ LIBER ✦

4′epidoxorubicin (Epi DX) in elderly or unfit patients (pts) with small cell lung cancer (SCLC): a phase II experience by the EORTC Lung Cancer Cooperative Group

✍ Scribed by Quoix, E.; Karnicka, H.; Jassem, J.; Wiatr, E.; Cortes Funes, H.; Roozendaal, K.; Ten Velde, G.J.M.; Kirkpatrick, A.; van Zandwijk, N.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epirubicin in previously untreated patie

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Epirubicin in previously untreated patie

✍ Quoix, Elisabeth A.; Giaccone, Giuseppe; Jassem, Jacek; Karnicka, Hanna; Wiatr, 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 539 KB

Erlotinib and Bevacizumab in Newly Diagn

✍ Riggs, Heather; Jalal, Shadia I.; Baghdadi, Tareq Al; Bhatia, Sumeet; McClean, J 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 263 KB

Thoracic radiotherapy with or without da

✍ Shinji Atagi; Masaaki Kawahara; Akira Yokoyama; Hiroaki Okamoto; Nobuyuki Yamamo 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 216 KB

P-548 A multicenter phase II study of do

✍ Le Caer, H.; Gimenez, C.; Chouaid, C.; Jullian, H.; Le Treut, J.; Bombaron, P.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 253 KB

P-496 A multicenter phase II study of do

✍ Hervé, L.; Céline, G.; Christos, C.; Hervé, J.; Jacques, L.; Pierre, B.; Laurenc 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 131 KB